7 is the total number of securities Pharmstandard International S.A. has owned. The longest Pharmstandard International S.A. has owned a single stock is 8 quarters.
| Period | Weighting | Quarter | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
| PTGX | Protagonist Therapeuti... | 8 | 8 | 18.63% | 28.79% | 50.60% | Q4 2016 | Q3 2018 | 8 |
| ARGS | Argos Therapeutics Inc. | 8 | 8 | 0.29% | 17.34% | 55.88% | Q4 2016 | Q3 2018 | 8 |
| PRTO | Proteon Therapeutics Inc. | 8 | 8 | 1.91% | 7.94% | 15.80% | Q4 2016 | Q3 2018 | 8 |
| ARGS | Argos Therapeutics Inc. | 8 | 8 | 0.09% | 6.94% | 23.59% | Q4 2016 | Q3 2018 | 8 |
| JNCE | Jounce Therapeutics, Inc. | 7 | 7 | 8.68% | 25.28% | 38.85% | Q1 2017 | Q3 2018 | 7 |
| ALNA | Allena Pharmaceuticals | 4 | 4 | 10.73% | 29.40% | 45.90% | Q4 2017 | Q3 2018 | 4 |
| NTGN | Neon Therapeutics Inc. | 1 | 1 | 17.31% | 17.31% | 17.31% | Q3 2018 | Q3 2018 | 1 |
Download | |||||||||
The securities at the top of the list , including Protagonist Therapeutics, Inc., Argos Therapeutics Inc., and Proteon Therapeutics Inc., are the highest-conviction holdings of Pharmstandard International S.A..
The conviction is calculated by counting the number of quarters a security has been reported by Pharmstandard International S.A.. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that Pharmstandard International S.A. owns currently or has owned in the past.